HIV trial points to semaglutide as a new anti-aging contender

	HIV/AIDS
	The latest HIV/AIDS news from News Medical

	HIV trial points to semaglutide as a new anti-aging contender Once-weekly semaglutide significantly slowed epigenetic aging in adults with HIV-associated lipohypertrophy, as measured by multiple DNA methylation clocks in a randomized controlled trial. These exploratory findings suggest GLP-1 receptor agonists could impact biological aging but require further validation in broader populations.

	Deep staff cuts at a little-known federal agency pose trouble for droves of local health programs A little-known federal agency that sends more than $12 billion annually to support community health centers, addiction treatment services, and workforce initiatives for America's neediest people has been hobbled by the Trump administration's staffing purges.

How early immune challenges influence oral and systemic health in children

Once viewed only as infectious invaders, bacteria are now understood to play an important role in overall health.

	Inside the CDC, shooting adds to trauma as workers describe projects, careers in limbo Centers for Disease Control and Prevention workers whose jobs have been reinstated after dizzying Trump administration disruptions say they remain stuck in a budgetary, political, and professional limbo.

	Conditional cash transfer programs linked to reduction in AIDS cases and deaths among Brazilian women The world's largest conditional cash transfer programme, the Bolsa Família Programme (BFP), is associated with a substantial reduction in AIDS cases and deaths, especially among brown and black women with lower income and limited education.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025